NCT01613794View on ClinicalTrials.gov

Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis

NACompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Deep Vein ThrombosisPulmonary Embolism
Interventions
DRUG

Rosuvastatin

20 mg od

Trial Locations (3)

2134TM

Trombosedienst Medial, Hoofddorp

2300RC

Leiden anticoagulation clinic, Leiden

Unknown

Erasmus Medical Center, Rotterdam

All Listed Sponsors
collaborator

Netherlands Heart Foundation

OTHER

lead

Leiden University Medical Center

OTHER

NCT01613794 - Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis | Biotech Hunter | Biotech Hunter